Molecular interaction maps as information organizers and simulation guides

Chaos

Volumn 11, Issue 1, 2001, Pages 84-97

  Kohn, Kurt W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038027881     PISSN: 10541500     EISSN: None     Source Type: Journal    
DOI: 10.1063/1.1338126     Document Type: Review

References (46)

1. K. W. Kohn, " Molecular interaction map of the mammalian cell cycle control and DNA repair systems, " Mol. Biol. Cell 10, 2703 (1999).
2. K. W. Kohn, " Functional capabilities of molecular network components controlling the mammalian G1/S cell cycle phase transition, " Oncogene 16, 1065 (1998).
3. D. Bray, " Signaling complexes: Biophysical constraints on intracellular communication, " Annu. Rev. Biophys. Biomol. Struct. 27, 59 (1998).
4. T. Pawson and P. Nash, " Protein-protein interactions define specificity in signal transduction, " Genes Dev. 14, 1027 (2000).
5. G. Wang, U. S. Bhalla, and R. Iyengar, " Complexity in biological signaling systems, " Science 284, 92 (1999).
6. D. Bray and S. Lay, " Computer-based analysis of the binding steps in protein complex formation, " Proc. Natl. Acad. Sci. U.S.A. 94, 13493 (1997).
7. C. J. Morton-Firth and D. Bray, " Predicting temporal fluctuations in an intracellular signalling pathway, " J. Theor. Biol. 192, 117 (1998).
8. H. H. McAdams and A. Arkin, " It's a noisy business! Genetic regulation at the nanomolar scale, " Trends Genet. 15, 65 (1999).
9. P. H. Kussie, S. Gorina, V. Marechal et al., " Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain, " Science 274, 948 (1996).
10. T. Pawson and J. D. Scott, " Signaling through scaffold, anchoring, and adaptor proteins, " Science 278, 2075 (1997).
11. A. J. Whitmarsh and R. J. Davis, " Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals, " Trends Biochem. Sci. 23, 481 (1998).
12. W. Xu, A. Doshi, M. Lei et al., " Crystal structures of c-Src reveal features of its autoinhibitory mechanism, " Molec. Cell 3, 629 (1999).
13. S. Gonfloni, A. Weijland, J. Kretzschmar et al., " Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src, " Nat. Struct. Biol. 7, 281 (2000).
14. D. A. Tice, J. S. Biscardi, A. L. Nickles et al., " Mechanism of biological synergy between cellular Src and epidermal growth factor receptor, " Proc. Natl. Acad. Sci. U.S.A. 96, 1415 (1999).
15. X.-M. Zheng, R. J. Resnick, and D. Shalloway, " A phosphotyrosine displacement mechanism for activation of Src by PTPalpha, " EMBO J. 19, 964 (2000).
16. L. A. Cary and J. A. Cooper, " Molecular switches in lipid rafts, " Nature (London) 404, 945 (2000).
17. M. Kawabuchi, Y. Satomi, T. Takao et al., " Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases, " Nature (London) 404, 999 (2000).
18. S. Takeuchi, Y. Takayama, A. Ogawa et al., " Transmembrane phosphoprotein Cbp positively regulates the activity of the carboxyl-terminal Src kinase, Csk, " J. Biol. Chem. 275, 29183 (2000).
19. J. S. Biscardi, D. A. Tice, and S. J. Parsons, " c-Src, receptor tyrosine kinases, and human cancer, " Adv. Cancer Res. 76, 61 (1999).
20. N. Dyson, " The regulation of E2F by pRB-family proteins (Review), " Genes Dev. 12, 2245 (1998).
21. K. Ohtani, " Implications of transcription factor E2F in regulation of DNA replication, " Front. Biosci. 4, d793 (1999).
22. H. Muller and K. Helin, " The E2F transcription factors: Key regulators of cell proliferation, " Biochim. Biophys. Acta 1470, M1 (2000).
23. S. He, B. L. Cook, B. E. Deverman et al., " E2F is required to prevent inappropriate S-phase entry of mammalian cells, " Mol. Cell. Biol. 20, 363 (2000).
24. G. Marzio, C. Wagener, I. Gutierrez et al., " E2F family members are differentially regulated by reversible acetylation, " J. Biol. Chem. 275, 10887 (2000).
25. J. Karlseder, H. Rotheneder, and E. Wintersberger, " Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F, " Mol. Cell. Biol. 16, 1659 (1996).
26. S-Y. Lin, A. R. Black, D. Kostic et al., " Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction, " Mol. Cell. Biol. 16, 1668 (1996).
27. G. Watanabe, C. Albanese, R. J. Lee et al., " Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1, " Mol. Cell. Biol. 18, 3212 (1998).
28. R. X. Luo, A. A. Postigo, and D. C. Dean, " Rb interacts with histone deacetylase to repress transcription, " Cell 92, 463 (1998).
29. A. Brehm, E. A. Miska, D. J. McCanee et al., " Retinoblastoma protein recruits histone deacetylase to repress transcription, " Nature (London) 391, 597 (1998).
30. Y. Takahashi, J. B. Rayman, and B. D. Dynlacht, " Analysis of promoter binding by the E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression, " Genes Dev. 14, 804 (2000).
31. S. R. Datta, A. Brunet, and M. E. Greenberg, " Cellular survival: A play in three Akts, " Genes Dev. 13, 2905 (1999).
32. B. Fadeel, B. Zhivotovsky, and S. Orrenius, " All along the watchtower: On the regulation apoptosis regulators, " FASEB J. 13, 1647 (1999).
33. I. Galetic, M. Andjelkovic, R. Meier et al., " Mechanism of protein kinase B activation by insulin/insulin-like growth factor-1 reavealed by specific inhibitors of phosphoinositide-3-kinase - Significance for diabetes and cancer, " Pharmacol. Therap. 82, 409 (1999).
34. R. Brent, " Genomic biology, " Cell 100, 169 (2000).
35. M. Andjelkovic, S-M. Maira, P. Cron et al., " Domain swapping used to investigate the mechanism of protein kinase B regulation by 3-phosphoinositide-dependent protein kinase 1 and Ser473 kinase, " Mol. Cell. Biol. 19, 5061 (1999).
36. G. Tzivion, Z. Luo, and J. Avruch, " A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity, " Nature (London) 394, 88 (1998).
37. G. Carpenter, " The EGF receptor: A nexus for trafficking and signaling, " BioEssays 22, 697 (2000).
38. T. O. Chan, S. E. Rittenhouse, and P. N. Tsichlis, " Akt/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation, " Annu. Rev. Biochem. 68, 965 (1999).
39. L. E. Rameh and L. C. Cantley, " The role of phosphoinositide 3-kinase lipid products in cell function, " J. Biol. Chem. 274, 8347 (1999).
40. R. A. Anderson, I. V. Boronenkov, S. D. Doughman et al., " Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes, " J. Biol. Chem. 274, 9907 (1999).
41. T. F. J. Martin, " Phosphoinositide lipids as signaling molecules: Common themes for signal transduction, cytoskeletal regulation, and membrane trafficking, " Annu. Rev. Cell Dev. Biol. 14, 231 (1998).
42. T. Itoh et al., "Autophosphorylation of type I phosphatidylinositol phosphate kinase regulates its lipid kinase activity," J. Biol. Chem. (Published electronically on 20 April 2000 as manuscript M000426200) (2000).
43. D. A. Fruman, R. E. Meyers, and L. C. Cantley, " Phosphoinositide kinases, " Annu. Rev. Biochem. 67, 481 (1998).
44. S. J. Leevers, B. Vanhaesebroeck, and M. D. Waterfield, " Signalling through phosphoinositide 3-kinases: The lipids take centre stage, " Curr. Opin. Cell Biol. 11, 219 (1999).
45. M. F. Aman, T. D. Lamkin, H. Okada et al., " The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells, " J. Biol. Chem. 273, 33922 (1998).
46. S. M. Jones, R. Klinghoffer, G. D. Prestwich et al., " PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1, " Curr. Biol. 9, 512 (1999).